WINTER SPRINGS, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (IRMD) was recently named one of Fortune’s 100 Fastest Growing Companies for 2024. Iradimed is a leader in the development ...

WINTER SPRINGS, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 fourth quarter financial results before the market ...

WINTER SPRINGS, Fla., Oct. 26, 2017 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced FDA 510(k) clearance of its 3880 Magnetic Resonance Imaging (“MRI”) compatible patient vital ...

WINTER SPRINGS, Fla., Dec. 10, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (IRMD), today announced it has been ranked 24 th on Forbes’ list of America’s Most Successful Small-Cap Companies 2025.

WINTER SPRINGS, Fla., April 28, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 first quarter financial results before the market ...

Iradimed Corporation will participate in the 37th Annual Roth Conference, conducting one-on-one investor meetings on March 17-18, 2025. Iradimed Corporation announced its participation in the 37th ...

IRADIMED CORPORATION is scheduled to present at the prestigious 43rd Annual J.P. Morgan Healthcare Conference, which elevates the company's visibility within the healthcare sector. The company ...

ORLANDO, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative magnetic resonance imaging (MRI)-compatible medical devices, today announced its ...